Web Analytics

3 Latest Announced Rounds

  • $23,000,000
    Series B

    1 Investors

    Medical Device
    May 30th, 2025
  • $4,000,000
    Seed

    2 Investors

    Information Technology & Services
    May 30th, 2025
  • $10,000,000
    Series A

    3 Investors

    Financial Services
    May 30th, 2025
$545.74M Raised in 54 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Synvect

start up
United States - San Diego, CA
  • 14/03/2025
  • Seed
  • $3,000,000

A biotechnology platform to develop safe, scalable, and effective solutions to eliminate disease-transmitting vectors, starting with the world's deadliest animal: the mosquito.


Related People

Nikolay KandulCo Founder

Nikolay Kandul United States - San Diego, California

Nikolay is the co-founder and CEO of Synvect, a company dedicated to developing and commercializing next-generation, safe, and effective products for the biological elimination of mosquitoes. These innovative solutions aim to block the transmission of mosquito-borne diseases and eliminate biting nuisances, advancing public health worldwide.

Nikolay is deeply passionate about inventing, developing, and applying transformative technologies for societal benefit and public health. His extensive scientific background spans entomology, evolution, genetics, molecular biology, and genetic engineering. He is also the inventor of numerous genetic tools, reagents, and technologies that drive innovation in the field.

Synvect is seeking individuals with extensive experience in husbandry, genetics, and transgenesis of Aedes, Culex, and Anopheles mosquitoes. If you’re interested in joining the Synvect team to scale transformative technologies aimed at eradicating malaria, dengue, and other global killers, please don’t hesitate to reach out!